Becton, Dickinson and Company (NYSE:BDX) Raises Dividend to $1.06 Per Share

Becton, Dickinson and Company (NYSE:BDX) announced a quarterly dividend on Thursday, November 5th. Shareholders of record on Thursday, December 10th will be paid a dividend of $1.06 per share by the medical instruments supplier on Thursday, December 31st. This represents a $4.24 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date of this dividend is Thursday, December 10th. This is a 1.0% increase from Becton, Dickinson and Company’s previous quarterly dividend of $1.05.

Becton, Dickinson and Company has increased its dividend by an average of 0.1% per year over the last three years and has increased its dividend annually for the last 53 consecutive years. Becton, Dickinson and Company has a dividend payout ratio of 28.5% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Becton, Dickinson and Company to earn $13.24 per share next year, which means the company should continue to be able to cover its $4.20 annual dividend with an expected future payout ratio of 31.7%.

Becton, Dickinson and Company Stock Up 1.8%

NYSE BDX traded up $3.86 on Thursday, hitting $213.05. 3,990,398 shares of the company were exchanged, compared to its average volume of 2,439,275. The company has a current ratio of 0.87, a quick ratio of 0.51 and a debt-to-equity ratio of 0.55. The company has a market cap of $58.70 billion, a PE ratio of 64.17, a PEG ratio of 13.36 and a beta of 0.22. The stock has a fifty day moving average of $187.23 and a 200-day moving average of $170.20. Becton, Dickinson and Company has a 12 month low of $127.59 and a 12 month high of $214.78.

Becton, Dickinson and Company (NYSE:BDX) last posted its quarterly earnings results on Thursday, November 5th. The medical instruments supplier reported $4.15 earnings per share for the quarter, beating the consensus estimate of $4.07 by $0.08. The firm had revenue of $5.27 billion during the quarter, compared to the consensus estimate of $5.11 billion. Becton, Dickinson and Company had a net margin of 4.52% and a return on equity of 14.79%. The business’s revenue was up 5.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.96 earnings per share. As a group, analysts forecast that Becton, Dickinson and Company will post 12.67 earnings per share for the current year.

About Becton, Dickinson and Company

Becton, Dickinson and Company, commonly known as BD, is a global medical technology company that develops, manufactures and sells a broad range of products used by healthcare providers, clinical laboratories, pharmaceutical companies and patients. Its offerings support medication delivery, diagnostics, infection prevention, surgical care and other clinical procedures.

BD’s products include needles, syringes, injection devices, intravenous administration systems, medication-management technologies, specimen-collection products, diagnostic systems and laboratory instruments.